title: [Targeted therapies].
abstract: The definition of targets in the metastatic process has been a major step. Targeted therapy is composed of molecules which block these targets including ligand-binding antibody or receptor-inhibitors. Their mechanisms of action are not limited to angiogenesis but also concern apoptosis, bone marrow progenitor stem cells, vascularisation and immune response. An important number of drugs is still approved. However the metastatic disease is not yet curable. A better understanding will lead to develop others new targeted molecules or more efficient combination therapy.
authors.affiliation: Service d'Urologie, Université Paris Descartes, France. arnaud.mejean@nck.aphp.fr
authors.forename: A
authors.initials: A
authors.lastname: Méjean
authors.forename: T
authors.initials: T
authors.lastname: Lebret
mesh_terms: D006801:Humans; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D042461:Vascular Endothelial Growth Factor A